These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30170755)

  • 1. Use of telavancin in adolescent patients with cystic fibrosis and prior intolerance to vancomycin: A case series.
    Bernstein AT; Leigh MW; Goralski JL; Esther CR; McKinzie CJ
    J Cyst Fibros; 2018 Nov; 17(6):e48-e50. PubMed ID: 30170755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of Telavancin against Staphylococcus aureus Isolates, Including Those with Decreased Susceptibility to Ceftaroline, from Cystic Fibrosis Patients.
    Roch M; Varela MC; Taglialegna A; Rose WE; Rosato AE
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29914961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of telavancin in hospital-acquired pneumonia and ventilator-associated pneumonia.
    Sandrock CE; Shorr AF
    Clin Infect Dis; 2015 Sep; 61 Suppl 2():S79-86. PubMed ID: 26316561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time Course and Extent of Renal Function Changes in Patients Receiving Treatment for Staphylococcal Pneumonias: An Analysis Comparing Telavancin and Vancomycin from the ATTAIN Trials.
    Nogid B; Lacy MK; Jacobs M; Bruss J; Dwyer J
    Pharmacotherapy; 2018 Oct; 38(10):990-998. PubMed ID: 30003567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic management of methicillin-resistant Staphylococcus aureus--associated acute pulmonary exacerbations in cystic fibrosis.
    Fusco NM; Toussaint KA; Prescott WA
    Ann Pharmacother; 2015 Apr; 49(4):458-68. PubMed ID: 25583881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of Telavancin in Adult Patients with Cystic Fibrosis during Acute Pulmonary Exacerbation.
    Kidd JM; Sakon CM; Oleksiuk LM; Cies JJ; Pettit RS; Nicolau DP; Kuti JL
    Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31685468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telavancin for the treatment of hospital-acquired pneumonia: findings from the ATTAIN studies.
    Nannini EC; Corey GR; Stryjewski ME
    Expert Rev Anti Infect Ther; 2012 Aug; 10(8):847-54. PubMed ID: 23030322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of telavancin in the treatment of MRSA infections in hospital.
    Bassetti M; Mikulska M; Righi E; Nicolini L; Viscoli C
    Expert Opin Investig Drugs; 2009 Apr; 18(4):521-9. PubMed ID: 19335280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eradication strategy for persistent methicillin-resistant Staphylococcus aureus infection in individuals with cystic fibrosis--the PMEP trial: study protocol for a randomized controlled trial.
    Jennings MT; Boyle MP; Weaver D; Callahan KA; Dasenbrook EC
    Trials; 2014 Jun; 15():223. PubMed ID: 24925006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telavancin versus vancomycin for hospital-acquired pneumonia due to gram-positive pathogens.
    Rubinstein E; Lalani T; Corey GR; Kanafani ZA; Nannini EC; Rocha MG; Rahav G; Niederman MS; Kollef MH; Shorr AF; Lee PC; Lentnek AL; Luna CM; Fagon JY; Torres A; Kitt MM; Genter FC; Barriere SL; Friedland HD; Stryjewski ME;
    Clin Infect Dis; 2011 Jan; 52(1):31-40. PubMed ID: 21148517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. State of the art in cystic fibrosis pharmacology-Optimization of antimicrobials in the treatment of cystic fibrosis pulmonary exacerbations: I. Anti-methicillin-resistant Staphylococcus aureus (MRSA) antibiotics.
    Epps QJ; Epps KL; Young DC; Zobell JT
    Pediatr Pulmonol; 2020 Jan; 55(1):33-57. PubMed ID: 31609097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of telavancin and vancomycin for treatment of methicillin-resistant Staphylococcus aureus infections: A meta-analysis.
    Liu Y; Wang J
    Int J Clin Pharmacol Ther; 2017 Nov; 55(11):839-845. PubMed ID: 28793957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telavancin.
    Lyseng-Williamson KA; Blick SK
    Drugs; 2009; 69(18):2607-20. PubMed ID: 19943710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eradication of persistent methicillin-resistant Staphylococcus aureus infection in cystic fibrosis.
    Dezube R; Jennings MT; Rykiel M; Diener-West M; Boyle MP; Chmiel JF; Dasenbrook EC
    J Cyst Fibros; 2019 May; 18(3):357-363. PubMed ID: 30131297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ATTAIN trials: efficacy and safety of telavancin compared with vancomycin for the treatment of hospital-acquired and ventilator-associated bacterial pneumonia.
    Barriere SL
    Future Microbiol; 2014; 9(3):281-9. PubMed ID: 24450506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-world use of telavancin in the treatment of osteomyelitis.
    Saravolatz LD; Cleveland KO; Rikabi K; Hassoun A; Reilly J; Johnson LB; Spak C; Valenti S; Szpunar S
    Diagn Microbiol Infect Dis; 2019 Oct; 95(2):185-190. PubMed ID: 31256939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telavancin in the treatment of Staphylococcus aureus hospital-acquired and ventilator-associated pneumonia: clinical evidence and experience.
    Liapikou A; Dimakou K; Toumbis M
    Ther Adv Respir Dis; 2016 Aug; 10(4):368-78. PubMed ID: 27340253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telavancin: a review of its use in patients with nosocomial pneumonia.
    Scott LJ
    Drugs; 2013 Nov; 73(16):1829-39. PubMed ID: 24190596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective Antimicrobial Stewardship Strategies for Cost-effective Utilization of Telavancin for the Treatment of Patients With Hospital-acquired Bacterial Pneumonia Caused by Staphylococcus aureus.
    McKinnell JA; Corman S; Patel D; Leung GH; Gordon LM; Lodise TP
    Clin Ther; 2018 Mar; 40(3):406-414.e2. PubMed ID: 29454592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telavancin-associated acute kidney injury
.
    Cavanaugh C; Moeckel GW; Perazella MA
    Clin Nephrol; 2019 Mar; 91(3):187-191. PubMed ID: 30614441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.